Skip to content

PRA Group PRAA Subpart F income

Subpart F income at other companies

Wingstop logo
WingstopWING
$1.76M
Mativ Holdings logo
Mativ HoldingsMATV
$0
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$24.35M
Albany International Inc. logo
Albany International Inc.AIN
$138K
Baxter International logo
Baxter InternationalBAX
$4.5M-30.8%
Albany International Inc. logo
Albany International Inc.AIN
-0.9%

Other financials

Income statement

See full
Revenue$314.5M+16.7%
Operating income$103.3M+38.5%
Net income$28.2M+671%
EPS (diluted)$0.73+711%

Balance sheet

See full
Cash & equivalents$124.8M-3.0%
Total debt$3.8B+9.0%
Total equity$1.0B-17.8%
Total assets$5.2B+1.1%

Cash flow

See full
Operating cash flow$24.9M+147%
CapEx$1.4M+56.7%
Free cash flow$23.5M+144%

Valuation

See full
Market cap$693.4M+19.1%
Enterprise value$4.38B+10.9%
P/S0.6×0.0×

Profitability

See full
Operating margin-5.3%-33.2pp
Net margin-29.5%-33.7pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-32%-35.7pp
Debt / equity3.8×+0.9×

Where this comes from

Reported directly by PRA Group in its filing.

Tagged under the XBRL concept praa:EffectiveIncomeTaxRateReconciliationSubpartFIncomeAmount.

The official record: PRA Group’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about PRA Group's subpart f income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PRA Group's subpart f income?
PRA Group (PRAA) reported subpart f income of $3.58M in Q4 2025.
What does subpart f income mean?
Measures the amount of income earned by foreign subsidiaries that is subject to immediate U.S. taxation under Subpart F rules. This metric highlights the portion of foreign earnings that do not qualify for deferral and are treated as currently taxable in the United States. It reflects the company's exposure to specific international tax compliance requirements.